Breast Augmentation With Autologous Fat Stem Cells

Clinic DDr. Heinrich Leads in Breast Augmentation With Autologous Stem Cells

VIENNA, Austria, April 6, 2010 – Whereas US and European medical centers are still beginners in breast
augmentation with stem cell-enriched autologous fat, Viennese New Cosmetic
Surgery and anti-aging expert DDr. Karl-Georg Heinrich is well-versed in this
revolutionary method. In his Clinic DDr. Heinrich, he has been [...]

Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry!

LONDON, April 6, 2010 – The economic recovery process has proved difficult for the pharmaceutical
industry. Factors like patent expiry, dry pipeline, and strict approval
guidelines have slowed down the attractive drug discovery and industry
growth. Coupled with an investment risk in new therapy or molecules, this
creates a challenge for the industry to overcome. However, in the [...]

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan

TOKYO, April 6, 2010 – Daiichi Sankyo Company, Limited announced today that it has
submitted a New Drug Application to the Ministry of Health, Labor and Welfare
in Japan seeking approval of the anticoagulant, edoxaban, for the prevention
of venous thromboembolism (VTE) after major orthopedic surgery.
[...]

Clearstone Hires Quality Assurance Leader

TORONTO, April 6, 2010 – Clearstone Central Laboratories, a leading global provider of clinical
laboratory and centralized cardiac services for clinical trials, today
announced the appointment of Rose Buot as Vice President of Global Quality
Assurance. She will report directly to Clearstone CEO Lewis Cameron and work
from the company's Baillet-en-France laboratory, near Paris, France.

[...]

Accumetrics, Inc. Announces Completion of GRAVITAS Trial Enrollment

SAN DIEGO, April 6, 2010 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy to use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, announced that
it has completed the enrollment phase of its landmark clinical trial,
GRAVITAS (Gauging Responsiveness with A VerifyNow(R) Assay Impact on
Thrombosis And Safety). [...]